Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit

By Katryna Perera · March 29, 2024, 5:30 PM EDT

A New York federal judge has granted a win to hedge fund Armistice Capital LLC and its managing member in a derivative suit brought by a shareholder of biotechnology company Vaxart...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Roth v. Armistice Capital, LLC et al

Case Number

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

October 23, 2020

Recent Articles By Katryna

May 02, 2024
Masimo Hit With Derivative Suit Over Audio Co. Acquisition
May 01, 2024
Insulin Pump Maker Wins Toss of Investor Suit For Now
April 30, 2024
Vaxart Investors Want Sanctions Over Deleted Texts
April 08, 2024
Walmart Beats Investor Suit Over Opioid Probe Disclosures
March 18, 2024
Biotech Ardelyx Beats Shareholder Suit Over Kidney Drug
March 11, 2024
Illumina Brass Faces Shareholder Suit Over Grail Deal Debacle
February 15, 2024
Citadel Securities, Others Beat Biotech Spoofing Suit, For Now
February 06, 2024
Judge Won't Toss All Claims In COVID Test Securities Action
January 29, 2024
Hearing Aid Co. Eargo Investors Ask 9th Circ. To Revive Suit
January 25, 2024
Danaher Execs Face Investor Suit Over Post-Pandemic Slump